Bottom cards (Which this is) does not render the title text, so what you put here doesn't matter.

Opt-out laws designed to make organ donation easier may have actually made it harder, says research

Can anything stop the exodus of doctors heading overseas?

Breathing may introduce microplastics to the brain – new study

The NHS is in 'serious trouble' and needs major reform – here are the pitfalls the government must avoid 

Analysis and Opinion

# The news that impacts UK doctors

A global study, led by University College London and its associated hospital group, found that compared to single-agent chemotherapy, atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer (NSCLC) patients who were not able to be treated with platinum-containing chemotherapy.

Promising immunotherapy for ‘difficult to treat’ lung cancer patients

An immunotherapy for a difficult to treat lung cancer has shown promise after it improved overall survival, British researchers reported today.

Log in or join for free to read more

You might also like